Stock Market

In this article

Signage is seen ahead of the IPO for Chewy at the New York Stock Exchange, June 14, 2019.
Andrew Kelly | Reuters

Check out the companies making headlines after the bell on Tuesday:

Chewy – Shares of the pet-product retailer rose 8% after the company reported fourth-quarter results that topped analyst expectations. Chewy reported earnings per share of 5 cents on revenue of $2.04 billion. Analysts surveyed by Refinitiv expected losses per share of 10 cents on revenue of $1.96 billion.

PVH Corp. – Shares of the closing company slid 1% after the company logged a fourth-quarter revenue that missed analyst expectations. PVH posted a revenue of $2.09 billion. Analysts polled by Refinitiv predicted sales of $2.12 billion. The company lost an adjusted 38 cents per share, but it was unclear whether that was comparable to a Refinitiv forecast for a loss of 34 cents per share.

Lululemon – Lululemon shares dipped 0.7% even after the company reported better-than-expected fourth-quarter results. The athleticwear retailer posted earnings per share of $2.58 on revenue of $1.73 billion. Analysts surveyed by Refinitiv expected earnings per share of $2.49 on revenue of $1.66 billion.

Illumina – The biotechnology company’s shares slid 0.7% on light volume, putting the stock on track to build on its 6.6% drop from the regular session. Illumina shares were under pressure on Tuesday after the Federal Trade Commission filed a complaint to block the company’s acquisition of Grail, which makes tests for early cancer detection. The complaint alleges the deal “will diminish innovation in the U.S. market for MCED tests.”

Articles You May Like

Inside Louisiana’s landmark P3: Calcasieu Bridge Project and the future of infrastructure funding
From giant Lego-style bricks to artificial reefs, how the construction industry is using tech to tackle climate change
Here are the top 10 U.S. stock analysts, according to TipRanks
Commerzbank explores thousands of job cuts in answer to Andrea Orcel
Irenic takes a position at KBR. Here’s how the activist may help improve shareholder value